Sionna Therapeutics, Inc.
SION
$24.39
$0.652.74%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 262.57M | 269.67M | 147.54M | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 4.18M | 4.01M | 3.46M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 266.75M | 273.68M | 150.99M | -- | |
|
|
|||||
| Total Current Assets | 266.75M | 273.68M | 150.99M | -- | |
| Net Property, Plant & Equipment | 9.64M | 10.01M | 10.30M | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 962.00K | 962.00K | 3.96M | -- | |
| Total Assets | 352.05M | 369.67M | 185.75M | -- | |
|
|
|||||
| Total Accounts Payable | 914.00K | 5.02M | 1.19M | -- | |
| Total Accrued Expenses | 5.47M | 3.35M | 7.67M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 1.17M | 1.12M | 1.07M | -- | |
| Total Finance Division Other Current Liabilities | -- | 39.00K | 492.00K | -- | |
| Total Other Current Liabilities | -- | 39.00K | 492.00K | -- | |
| Total Current Liabilities | 7.55M | 9.53M | 10.42M | -- | |
|
|
|||||
| Total Current Liabilities | 7.55M | 9.53M | 10.42M | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 8.07M | 8.38M | 8.68M | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 15.62M | 17.91M | 19.10M | -- | |
|
|
|||||
| Common Stock & APIC | 551.88M | 549.04M | 17.01M | -- | |
| Retained Earnings | -215.64M | -197.57M | -181.09M | -- | |
| Treasury Stock & Other | 183.00K | 301.00K | 368.00K | -- | |
| Total Common Equity | 336.43M | 351.77M | -163.71M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | 330.37M | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | 330.37M | -- | |
|
|
|||||
| Total Common Equity | 336.43M | 351.77M | -163.71M | -- | |
| Total Preferred Equity | -- | -- | 330.37M | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 336.43M | 351.77M | 166.66M | -- | |
|
|
|||||